Jonsson Comprehensive Cancer Center
🇺🇸United States
Paclitaxel and Carboplatin in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2020-09-01
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 58
- Registration Number
- NCT00049257
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States
Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer
Phase 2
Completed
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2020-08-03
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT00024076
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
Vaccine Therapy in Treating Patients With Liver Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2020-08-03
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 33
- Registration Number
- NCT00022334
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or Stomach
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2020-08-03
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 51
- Registration Number
- NCT00020761
- Locations
- 🇺🇸
OHSU Cancer Institute, Portland, Oregon, United States
🇺🇸Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
🇺🇸Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States
Docetaxel and Trastuzumab With or Without Carboplatin in Treating Women With HER2-Positive Breast Cancer
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2020-08-03
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 263
- Registration Number
- NCT00047255
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
Monoclonal Antibody Therapy in Treating Patients With Metastatic Colorectal Cancer
Phase 2
Completed
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-01-08
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 44
- Registration Number
- NCT00039273
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
© Copyright 2024. All Rights Reserved by MedPath